Pharmaceutical Executive-09-01-2006

Pharmaceutical Executive

From the Editor: Undecided

September 01, 2006

From the Editor

0

0

The world according to New Hampshire: Doctors prescribe expensive drugs because pharma reps sell them. Interfere with the selling, and you'll cut down on the prescribing. It's a plan. But for what?

Legal: Authorized Generics: Still Legal—and Holding

September 01, 2006

Legal

0

0

Indeed, at this time, we are aware of no evidence that the practice of authorized generics has actually deterred any Paragraph IV certification or post-180 day generic entry, let alone a challenge to an invalid patent.

Public Access

September 01, 2006

Features

0

0

When people ask how health seekers look and act on the Web, there's no one answer: The online universe has become just as diverse as the rest of the world. Nowhere is this more evident than in the latest e-health statistics that, when taken together, paint a picture of customers who are beginning to find their feet-and new finesse-online.

Industry Audit

September 01, 2006

Executive Profile

0

0

For the fifth year in a row, Pharm Exec invites Professor Bill Trombetta of St. Joseph's University to analyze the pharma industry's financial performance with a battery of business metrics old and new. The highlights: Two top biotechs race neck-and-neck for first place, Forest delivers another strong performance, and AstraZeneca squeezes past Johnson & Johnson and GlaxoSmithKline into the top four for the first time ever. And the winner is . . .

Freedom of Information

September 01, 2006

Features

0

0

The suit draws a comparison to the newspaper industry: Even though papers profit from disseminating information, the information in question isn't commercial.

Direct to Consumer: No-Name Opportunity

September 01, 2006

Column

0

0

Most DTC marketers say education has been their primary goal all along, but that often, branded messages got in the way. Now marketers are doing something about it, as evidenced by recent increases in unbranded ads. Pharma companies are producing campaigns that more clearly encourage consumers to seek information about their conditions, rather than just running out and requesting a script from their doctors.